A new national study has found that melanoma patients with darker skin tones face more than twice the likelihood of experiencing delays in medical care compared to white patients, a disparity that could significantly impact survival rates and treatment outcomes. Researchers analyzing data from the National Health Interview Survey discovered that patients with skin of color reported higher rates of delayed care for multiple reasons, including inability to obtain appointments, difficulty reaching clinics by phone, lack of transportation, and extended wait times .

Why Are Melanoma Patients With Darker Skin Experiencing Longer Delays?

The study, published in the Journal of Drugs in Dermatology, examined self-reported melanoma patients across the United States and adjusted for sociodemographic factors to isolate the impact of race and ethnicity on care access. After controlling for these variables, patients with skin of color had more than twice the odds of experiencing delayed care compared with white patients . This finding suggests that systemic barriers within the healthcare system, rather than individual patient factors alone, are driving these disparities.

The barriers identified in the research paint a clear picture of the obstacles these patients face. Multiple access challenges compound to create significant delays in diagnosis and treatment. Understanding these specific barriers is crucial for healthcare providers and policymakers working to improve equitable care.

• Appointment Availability: Patients with skin of color reported greater difficulty securing melanoma care appointments, suggesting potential gaps in dermatology capacity or unequal distribution of specialists in their communities.
• Phone Access Issues: Difficulty reaching clinics by phone creates an additional barrier that prevents patients from even scheduling initial consultations or follow-up visits.
• Transportation Barriers: Lack of reliable transportation to dermatology clinics disproportionately affects patients with skin of color, particularly those in rural or underserved areas.
• Extended Wait Times: Once patients do secure appointments, long wait times further delay diagnosis and treatment initiation, potentially allowing melanoma to progress to more advanced stages.

How Can Healthcare Systems Address These Access Barriers?

The study highlights critical system-level obstacles that require targeted interventions. Healthcare providers and dermatology practices can take concrete steps to reduce these disparities and ensure timely melanoma detection and treatment for all patients, regardless of race or ethnicity.

• Clinic Workflow Improvements: Streamline scheduling systems and increase appointment availability, particularly in underserved communities with higher populations of patients with skin of color.
• Enhanced Phone Access: Implement dedicated phone lines, reduce hold times, and consider alternative scheduling methods such as online booking or text-based appointment systems to improve accessibility.
• Community Outreach Initiatives: Develop targeted outreach programs to educate patients with darker skin tones about melanoma risk, early warning signs, and the importance of regular skin checks, addressing the knowledge gap that may contribute to delayed care-seeking.
• Transportation Solutions: Partner with community organizations to provide transportation assistance or mobile dermatology clinics that bring care directly to underserved neighborhoods.

The implications of these delays extend beyond inconvenience. Melanoma is a serious form of skin cancer, and early detection is critical for survival. When diagnosis is delayed, patients are more likely to present with advanced-stage disease, which significantly reduces treatment options and survival rates. The research underscores that access barriers may contribute to later-stage diagnoses and poorer outcomes in patients with skin of color .

This disparity is particularly concerning because melanoma affects people of all skin tones. While melanoma is historically more common in white populations, it is often more deadly in patients with darker skin because it tends to be diagnosed at later stages. The combination of delayed care access and later-stage diagnosis creates a compounding effect that worsens prognosis for patients with skin of color.

The study's findings represent a call to action for dermatology practices, healthcare systems, and policymakers. Addressing these systemic barriers requires intentional effort and resource allocation. Healthcare providers must recognize that equal treatment is not enough; equitable treatment requires acknowledging and actively dismantling the structural obstacles that prevent patients with skin of color from accessing timely melanoma care. By implementing the workflow improvements, outreach strategies, and accessibility solutions identified in this research, the dermatology community can work toward ensuring that all patients receive the prompt, high-quality care they deserve.